Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Non-Muscle Invasive Bladder Neoplasms × Laser Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 2 Skin Neoplasms 2 Laryngeal Neoplasms 2 Dyspareunia 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Breast Neoplasms 2 Warts 1 Vulvar Neoplasms 1 Vomiting 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomatitis 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Radiodermatitis 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papilloma 1 Pain 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Laryngeal papillomatosis 1 Keratosis, Actinic 1

Interventions

Gemcitabine 15 Mitomycin 9 Docetaxel 7 BCG Vaccine 6 Cystoscopy 4 durvalumab 3 Radiotherapy 3 tislelizumab 2 disitamab vedotin 2 avelumab 2 Epirubicin 2 tremelimumab 1 toripalimab 1 pemigatinib 1 monalizumab 1 lornoxicam 1 erdafitinib 1 bicalutamide 1 VPM1002 recombinant BCG vaccine 1 Urine Specimen Collection 1 Ty21a typhoid vaccine 1 Transurethral Resection of Bladder 1 Therapeutics 1 Surveys and Questionnaires 1 Sugars 1 Saline Solution 1 Postoperative Period 1 Pentosan Sulfuric Polyester 1 Patient Discharge 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05337397 2022-08-08

OPTIMA

Aarhus University Hospital

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡